Whole body PD-1 and PD-L1 PET in pts with NSCLC

AL Niemeijer, E Smit, I Bahce, O Hoekstra… - Annals of …, 2017 - annalsofoncology.org
Background: Tumor PD-L1 IHC relates moderately with treatment outcome following anti-
PD1 therapy in pts with NSCLC and single biopsies do not account for tumor heterogeneity …
被引用次数：3 相关文章

MA 05.07 Whole Body PD-1 and PD-L1 PET in Pts with NSCLC

A Niemeijer, E Smit, G Van Dongen… - Journal of Thoracic …, 2017 - jto.org
Background Tumor PD-L1 IHC relates moderately with treatment outcome following anti-
PD1 therapy in pts with NSCLC and single biopsies do not account for tumor heterogeneity …

[引用][C] Whole body PD-1 and PD-L1 PET in pts with NSCLC

AL Niemeijer, E Smit, I Bahce… - Annals of …, 2017 - researchinformation.amsterdamumc …
Whole body PD-1 and PD-L1 PET in pts with NSCLC — Amsterdam UMC research portal
Skip to main navigation Skip to search Skip to main content Amsterdam UMC research portal …

[引用][C] Whole Body PD-1 and PD-L1 PET in Pts with NSCLC

A Niemeijer, E Smit… - Journal of …, 2017 - researchinformation.amsterdamumc …
Whole Body PD-1 and PD-L1 PET in Pts with NSCLC — Amsterdam UMC research portal Skip
to main navigation Skip to search Skip to main content Amsterdam UMC research portal Home …